Disease

Esophageal Cancer

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · PHASE 1 TRIAL

Phase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors

ClinicalTrials.gov

This is a Phase 1b trial registration with no results posted; it describes a planned open-label, single-arm safety and dose-escalation study in early-stage drug development.

PreliminaryNCT07806500 R01 Gastric Cancer

Reported

Planned enrollment18

PhasePhase 1b

Dose escalation levels240, 320, and 400 mg BID

SEP 8, 2026 · PHASE 1 TRIAL

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

ClinicalTrials.gov

This is a first-in-human Phase 1 trial registration with no results posted; the study is not yet recruiting and therefore represents early-stage, pre-clinical development work.

PreliminaryNCT07807345 Sutro Biopharma Head & Neck Squamous Cell Carcinoma

Reported

Planned enrollment285

Study phasePhase 1

Primary outcome (Part 1A, 1C): In…21 days

JUL 29, 2026 · JOURNAL ARTICLE

Protocol for a cohort study: evaluating the effect of neoadjuvant immunochemotherapy on intraoperative remifentanil consumption during IoC2-guided anesthesia in elderly patients with esophageal cancer.

Annals of Medicine

This is a protocol for a prospective observational cohort study not yet conducted; it describes planned methods and outcomes without results, establishing hypothesis-generating potential but lacking empirical evidence.

PreliminaryYuyan Ding Yuchen Lu Esophageal Neoplasms

Reported

nICT group30

Treatment-naive group30